|
CEP68 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.133000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.031900E-02 |
| Normal-vs-Stage2 |
3.751400E-01 |
| Normal-vs-Stage3 |
5.302400E-03 |
| Normal-vs-Stage4 |
6.28520000000021E-05 |
| Stage1-vs-Stage2 |
3.902200E-02 |
| Stage1-vs-Stage3 |
2.1910000003178E-07 |
| Stage1-vs-Stage4 |
1.39339995097743E-09 |
| Stage2-vs-Stage3 |
2.886000E-01 |
| Stage2-vs-Stage4 |
3.530200E-02 |
| Stage3-vs-Stage4 |
9.417900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.673200E-01 |
| Normal-vs-AfricanAmerican |
9.709000E-01 |
| Normal-vs-Asian |
8.951800E-01 |
| Caucasian-vs-AfricanAmerican |
5.776200E-01 |
| Caucasian-vs-Asian |
7.299200E-01 |
| AfricanAmerican-vs-Asian |
9.213000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.190760E-01 |
| Normal-vs-Female |
5.568400E-01 |
| Male-vs-Female |
1.527900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.936200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.498600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.315900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.795780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.951800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.398000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.067440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.544100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.779800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.833800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.364500E-03 |
| Normal-vs-Grade 2 |
5.950400E-02 |
| Normal-vs-Grade 3 |
3.898400E-03 |
| Normal-vs-Grade 4 |
2.15969999999288E-05 |
| Grade 1-vs-Grade 2 |
1.921490E-03 |
| Grade 1-vs-Grade 3 |
1.784380E-03 |
| Grade 1-vs-Grade 4 |
5.363300E-04 |
| Grade 2-vs-Grade 3 |
1.23769999804679E-08 |
| Grade 2-vs-Grade 4 |
3.9624004077865E-10 |
| Grade 3-vs-Grade 4 |
2.099900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.175900E-02 |
| Normal-vs-ccB subtype |
6.862100E-03 |
| ccA subtype-vs-ccB subtype |
3.96489999721084E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.800000E-01 |
| Normal-vs-N1 |
1.395360E-03 |
| N0-vs-N1 |
2.830200E-02 |
|
|
